Teva paid top executives $330m while share price tanked - Globes
Teva names Richard Francis to replace CEO Schultz - Medical Buyer
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva CEO steps down, replacement found — MedWatch
Kåre Schultz lands first chairmanship following Teva exit — MedWatch
Teva Pharmaceutical Industries names a new CEO
Teva Pharmaceuticals on LinkedIn: Richard Francis, Teva Pharmaceuticals President & CEO, appeared on…
Schultz kept Teva away from the abyss, but couldn't find a runway to growth | Ctech
Richard Francis - Teva Pharmaceuticals | LinkedIn
New Teva CEO reorganizes with an 'ax, not hedge clippers or pruning shears' - STAT
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised -August 02, 2023 at 03:19 pm EDT | MarketScreener
Israel's Teva Pharm to start paying US opioid settlement in 2023 -CEO - The Jerusalem Post
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO | Reuters
Teva Pharmaceuticals on X: "Speaking at #JPM2020, Teva CEO Kåre Schultz discussed the company's restructuring, future growth drivers, and a focus on the needs of patients and customers. Listen to a replay
Teva Pharma CEO Richard Francis on Q4 earnings
Teva CEO Erez Vigodman Steps Down | CHEManager
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
Teva Appoints New Chief Executive After Months of Speculation - WSJ
Teva CEO exits in ongoing crisis of confidence at drugmaker | Reuters
Teva CEO says production and distribution in Israel remain largely unaffected by war | The Times of Israel
Teva decided to appoint Richard Francis as President and CEO replacing Kar Schultz after 5 years :: Israeli Financial News - The Israeli Economic World
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
